Quantcast

Latest Incyte Corporation Stories

2010-01-28 05:30:00

INDIANAPOLIS, Jan.

2009-05-19 08:00:00

RESEARCH TRIANGLE PARK, N.C., May 19 /PRNewswire/ -- ArtusLabs, Inc. (www.artuslabs.com), the leader in scientifically-aware data management systems, today announced a collaborative license agreement with Incyte Corporation to address two prevalent industry problems.

2008-10-26 19:01:19

Incyte Corporation (Nasdaq:INCY) announced today the presentation of clinical results from a 28-day Phase IIa trial of INCB18424, its orally available janus kinase (JAK) inhibitor, in patients with rheumatoid arthritis (RA).

2008-09-18 09:00:11

Incyte Corporation (Nasdaq:INCY) reported positive results from two 28-day Phase IIa clinical trials of topical INCB18424, a selective janus-associated kinase (JAK) inhibitor, in patients with mild to moderate psoriasis.

2008-07-29 18:00:51

Incyte Corporation (Nasdaq:INCY) today announced its second quarter 2008 financial results and reported continued progress in several lead clinical programs.


Word of the Day
immane
  • Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.
The word 'immane' comes from the Latin word 'immanis', 'enormous'.
Related